Sankarasubbaiyan Suresh, Pollock Carol A, Anandh Urmila, Kasiviswanathan Savitha, Shah Kamal D
NephroPlus Dialysis Centers, Hyderabad, Telangana, India.
Department of Medicine, Northern Clinical School, Kolling Institute of Medical Research, The University of Sydney, Australia.
Indian J Nephrol. 2025 May-Jun;35(3):390-396. doi: 10.25259/ijn_563_23. Epub 2024 Aug 8.
Mortality in hemodialysis (HD) exceeds that of many solid organ cancers, despite advancements in care. This study was conducted to understand mortality in a large dialysis network of Indian HD patients and attempt to elucidate risk factors for mortality.
We performed a case-control study of deaths among patients undergoing HD across 203 centers in India from January 1 to March 31, 2021 with an age-matched control of survivors. We reviewed demographic, dialysis, clinical, and socioeconomic factors.
Out of 17,659 patients on dialysis, 554 cases (non-survivors) and 623 age-matched controls (survivors) patients were followed up. The mean age was 54.9 ± 13.8 years, 70.5% (391) of them were males. Gender, BMI, dialysis frequency, HD vintage time, history of diabetes, and heart failure were similar between non-survivors and survivors. Lower education level, payment under public insurance, dialysis facility under a public-private partnership, vascular access via catheter, hemoglobin <8 g/dL levels, serum albumin <3.5 g/dL were significantly higher, hospitalizations in 3 months prior to death were more frequent among non-survivors.
Factors including Hb <8 g/dL, temporary catheter, serum albumin less <3.5 g/dL, lower educational status, and dialysis under public insurance are associated with poorer survival in our population. Our findings have implications for designing interventions needed to improve outcomes for evolving policy and public-payer systems.
尽管医疗有所进步,但血液透析(HD)患者的死亡率仍超过许多实体器官癌症患者的死亡率。本研究旨在了解印度大型血液透析患者网络中的死亡率,并试图阐明死亡的危险因素。
我们对2021年1月1日至3月31日期间印度203个中心接受血液透析的患者死亡情况进行了病例对照研究,并对幸存者进行了年龄匹配的对照。我们回顾了人口统计学、透析、临床和社会经济因素。
在17659名接受透析的患者中,对554例(非幸存者)和623例年龄匹配的对照(幸存者)患者进行了随访。平均年龄为54.9±13.8岁,其中70.5%(391例)为男性。非幸存者和幸存者之间在性别、体重指数、透析频率、血液透析时间、糖尿病史和心力衰竭方面相似。非幸存者的教育水平较低、通过公共保险支付、公私合营的透析设施、通过导管进行血管通路、血红蛋白<8 g/dL水平、血清白蛋白<3.5 g/dL的比例显著更高,死亡前3个月的住院频率更高。
包括血红蛋白<8 g/dL、临时导管、血清白蛋白<3.5 g/dL、较低的教育水平以及公共保险下的透析等因素与我们研究人群的较差生存率相关。我们的研究结果对设计改善结果所需的干预措施具有启示意义,以适应不断发展的政策和公共支付系统。